- Research article
- Open access
- Published:
Trichinella spiralis dipeptidyl peptidase 1 suppressed macrophage cytotoxicity by promoting M2 polarization via the STAT6/PPARγ pathway
Veterinary Research volume 54, Article number: 77 (2023)
Abstract
Trichinella spiralis dipeptidyl peptidase 1 (TsDPP1), or cysteine cathepsin C, is a secretory protein that is highly expressed during the infective larvae and adult worm stages in the intestines. The aim of this study was to investigate the mechanism by which recombinant TsDPP1 (rTsDPP1) activates macrophages M2 polarization and decreases macrophage cytotoxicity to kill newborn larvae via ADCC. RAW264.7 macrophages and murine peritoneal macrophages were used in this study. The results of the immunofluorescence test (IFT) and confocal microscopy showed that rTsDPP1 specifically bound to macrophages, and the binding site was localized on the cell membrane. rTsDPP1 activated macrophage M2 polarization, as demonstrated by high expression levels of Arg1 (M2 marker) and M2-related genes (IL-10, TGF-β, CD206 and Arg1) and high numbers of CD206+ macrophages. Furthermore, the expression levels of p-STAT6, STAT6 and PPARγ were obviously increased in rTsDPP1-treated macrophages, which were evidently abrogated by using a STAT6 inhibitor (AS1517499) and PPARγ antagonist (GW9662). The results indicated that rTsDPP1 promoted macrophage M2 polarization through the STAT6/PPARγ pathway. Griess reaction results revealed that rTsDPP1 suppressed LPS-induced NO production in macrophages. qPCR and flow cytometry results showed that rTsDPP1 downregulated the expression of FcγR I (CD64) in macrophages. The ability of ADCC to kill newborn larvae was significantly decreased in rTsDPP1-treated macrophages, but AS1517499 and GW9662 restored its killing capacity. Our results demonstrated that rTsDPP1 induced macrophage M2 polarization, upregulated the expression of anti-inflammatory cytokines, and inhibited macrophage-mediated ADCC via activation of the STAT6/PPARγ pathway, which is beneficial to the parasitism and immune evasion of this nematode.
Introduction
Trichinella spiralis is a parasitic nematode that is distributed worldwide. It can infect a variety of mammals and human beings and cause trichinellosis [1]. In China, eight human trichinellosis outbreaks with 479 cases and 2 deaths were reported from 2009 to 2020, and the principal source of infection was pork from domestic pigs [2]. T. spiralis muscle larvae (ML) are released in the stomach after infected meat is digested by gastric fluid and develop into intestinal infective larvae (IIL) following activation by bile and gut contents [3]. The IIL migrate into the gut epithelia and develop into adult worms (AWs) after they moult four times at 31 h post-infection (hpi) [4]. After copulation in the small intestine, female adults deposit newborn larvae (NBL), which pass into the venules and lymphatic vessels and then spread throughout the body via blood circulation finally, they invade skeletal muscles and develop into encapsulated ML [5]. Trichinella infection elicits a substantial humoral and cellular immune response [6, 7], but ML residing in skeletal muscle capsules can survive from 1 to 2 years to 10–15 years based on the species of the host and even up to 30 years in humans without any major harm [8]. The long survival of T. spiralis in the host is likely related to its immunomodulation and immune escape [9].
Trichinella spiralis is a unique parasitic nematode in which both the AW and larvae occupy two different intracellular niches within the same host. Although T. spiralis infection triggers an intense host immune response, it can modulate the parasite-specific immune response to ensure the survival of both the host and parasite [10, 11]. In the process of T. spiralis infection, the excretory-secretory antigens (ESA) from the parasite play a principal role in establishing parasitism and modulating the immune response; they provide an anti-inflammatory milieu and maintain homeostasis [12]. The ESA from T. spiralis IIL, AW and ML contain some functional antigens, and they might be important potential immunomodulators in the host immune response [13,14,15]. In the early stage of Trichinella infection, multiple immune cell types are activated in the host to mainly generate a Th1 immune response that produces large amounts of inflammatory cytokines. As the infection progresses, the dominant immune response is switched from Th1 to Th2 to alleviate the tissue damage caused by the immune response through immune regulation and immunosuppression. The immunomodulatory and inhibitory effects are beneficial for the control of inflammation and pathological lesions resulting from T. spiralis infection and for its survival in the host [16].
Macrophages, as a kind of immune cell, play a variety of roles in phagocytosis, cellular immunity and molecular immunology [17]. In helminth infection, macrophages are activated into different inflammatory states, including classically activated macrophages (M1) induced by lipopolysaccharide (LPS) and IFN-γ and alternatively activated macrophages (M2) induced by IL-4 and IL-13. M1 macrophages have proinflammatory effects and are involved in the immune response to bacterial and intracellular pathogen infection. In contrast, M2-type macrophages have anti-inflammatory effects and functions in angiogenesis and wound healing, and M2 macrophages are also associated with Th2 reactions, such as antihelminthic immunity, asthma, and allergies. M1-type macrophages secrete proinflammatory cytokines (TNF-α, IL-1β and IL-6) to participate in the immune response and immune surveillance. M2-type macrophages play a key role in suppressing the immune response by inducing the secretion of inhibitory cytokines, such as IL-4, IL-10 and TGF-β [18].
Antibody-dependent cell-mediated cytotoxicity (ADCC) exerts a pivotal effect on protective immunity against Trichinella infection, and ADCC kills and destroys larvae, especially NBL [19, 20]. Macrophages, as the main effector cells of ADCC, exert their killing functions by binding their surface Fc receptor (FcR) to the Fc fragment of anti-Trichinella IgG antibodies. Moreover, activated macrophages produce proinflammatory cytokines (e.g., TNF-α and IFN-γ) to enhance their phagocytic function. Activated macrophages also secrete some killing molecules, such as nitric oxide (NO) and reactive oxygen species (ROS), to kill larvae [21, 22]. Recently, some studies have shown that T. spiralis infection or its ESA regulates the host’s immune response and mainly induces a Th2-type immune response, which secretes IL-4 and IL-13. These cytokines also activate macrophages and induce macrophage polarization towards M2 [23, 24].
Cathepsin C, also known as dipeptidyl peptidase 1 (DPP1), is a cysteine cathepsin with the unique functions of cleaving peptides and degrading macromolecular proteins. Previous studies showed that cathepsin C1 (CPC1) is crucial for Toxoplasma gondii growth and proliferation in host cells. CPC1 protein inhibited NF-κB activation and downregulated the expression of IL-1, IL-6, IL-12 and TNF-α. CPC1 might play an important role in the immune evasion of T. gondii [25]. A novel dipeptidyl peptidase 1 from Trichinella spiralis (TsDPP1; Gene bank: XP_003379334.1) has been identified in our laboratory; TsDPP1 was highly expressed at the IIL and AW stages, primarily located at the cuticle, stichosome and embryos of this parasite, and it was a secretory protein. Recombinant TsDPP1 (rTsDPP1) had the hydrolysing activity of natural DPP1. rTsDPP1 promoted the larval invasion of intestinal epithelial cells (IECs), whereas anti-rTsDPP1 serum and RNAi inhibited larval invasion of IECs, suggesting that TsDPP1 might be a potential target for an anti-Trichinella vaccine. However, the role of TsDPP1 in immune regulation and immune evasion during T. spiralis infection has not been reported in the literature.
In this study, RAW264.7 and mouse peritoneal macrophages were used to investigate the ability and mechanism of rTsDPP1 to activate macrophage polarization and kill NBL via ADCC. The results will reveal the regulatory effect of TsDPP1 on macrophage immune function in the process of T. spiralis infection and provide a basis for elucidating the host immune evasion of T. spiralis.
Materials and methods
Animals, parasites and cells
Eight-week-old female BALB/c mice were purchased from the Experimental Animal Center of Zhengzhou University. The animal experiment in this study was performed under the principle of National Guidelines for Experimental Animal Welfare (Minister of Science and Technology, People’s Republic of China, 2006). The animal experiment protocol in this study was approved by the Life Science Ethics Committee of Zhengzhou University (No. ZZUIRB GZR 2019 − 0544). The T. spiralis (ISS534) parasite used in this research was obtained from an infected pig in Henan Province of China and maintained by serial passage in BALB/c mice [26]. RAW264.7 macrophages were purchased from the Cell Bank of the Chinese Academy of Sciences, and the cells were incubated at 37 °C in 5% CO2 with DMEM containing 10% foetal bovine serum, 100 U/mL penicillin and 100 µg/mL streptomycin [27].
Preparation of T. spiralis adult worm ESA
The ML were recovered from infected murine muscle tissues 42 days post-infection (dpi) by the artificial digestion method as previously described [28]. In brief, T. spiralis-infected mice were sacrificed, and the murine carcass was digested with 1% pepsin and acidified water. The mice were orally infected with ML (4000 larvae per mouse). At 6 dpi, the AWs were collected from the intestine by incubating the intestine in 0.9% saline at 37 °C for 2 h. Following washes with saline, 6-day AWs were cultured at 5000 worms/mL in RPMI-1640 (Solarbio, Beijing, China) supplemented with 200 U penicillin/mL and 200 μg streptomycin/mL at 37 °C and 5% CO2 for 18 h. The NBL was collected, and culture medium containing AW ESA was concentrated by using a centrifugal filter (Millipore Amicon Ultra15, NMWL: 3000, USA) [29].
Preparation of rTsDPP1 and anti-rTsDPP1 polyclonal antibodies
The recombinant plasmid pET-32a/TsDPP1 was induced using 1 mM IPTG at 25 °C for 6 h and expressed in the prokaryotic expression system E. coli BL21 (DE3). rTsDPP1 was purified using a Ni–NTA His-tag affinity kit (Sangon Biotech., Shanghai, China) as previously described [30]. Purified rTsDPP1 was used to immunize mice to generate polyclonal antibodies. Briefly, 6-week-old mice were subcutaneously injected with 20 µg of rTsDPP1 emulsified with complete Freund’s adjuvant, followed by three boost immunizations with 20 µg of rTsDPP1 emulsified with incomplete Freund’s adjuvant at a 14-day interval. Seven days after the final immunization, blood was collected from the tail vein, and immune sera were collected [8].
Preparation of murine peritoneal macrophages
Murine peritoneal macrophages were prepared as previously described [4]. Mice were euthanized and soaked in 75% alcohol for 3–5 s. The mice were intraperitoneally injected with 5 mL of prechilled PBS, and the peritoneal wall was simultaneously pressed for 10 min. Under sterile conditions, the intraperitoneal fluid was aspirated and centrifuged at 250 g for 10 min at 4 °C. Peritoneal exudate cells (PEC) were adjusted to 5 × 106 cells/mL with DMEM containing 10% foetal bovine serum (HyClone, Logan, Utah, USA), 100 U/mL penicillin and 100 µg/mL streptomycin. After incubation at 37 °C and 5% CO2 for 4 h, the cells were washed 2–3 times with DMEM to remove unattached cells, and purified peritoneal macrophages were obtained [31, 32].
CCK-8 assay
The effect of rTsDPP1 on RAW264.7 macrophage cellular viability was determined using a Cell Counting Kit-8 assay (CCK-8; Solarbio, Beijing, China) [33, 34]. Briefly, the cells were seeded in a 96-well plate (approximately 1 × 103 cells per well) and cultured under the same conditions as described above. rTsDPP1, recombinant thioredoxin (TRX) tag protein and AW ESA were added into the medium and cocultured with cells for 48 h. Then, 10 µL CCK-8 solutions were added to each well and incubated for another 2 h. The absorbance at 450 nm was measured using a multimode reader (SpectraMax i3X; Molecular Devices, USA). Cell viability was presented as the cell survival rate according to the following formulas: cell survival rate = (OD values of test group – OD values of blank control)/(OD values of PBS control group – OD values of blank control) × 100%.
In vitro stimulation of RAW264.7 and peritoneal macrophages with rTsDPP1
RAW264.7 and peritoneal macrophages were cultivated in the presence of various stimulating factors. rTsDPP1, TRX tag protein and T. spiralis AW ESA (20 µg/mL) were added to the medium, LPS (200 ng/mL) and IL-4 (20 ng/mL) were used as macrophage M1/M2 polarization positive controls, and PBS was used as a negative control [35]. After incubation at 37 °C in 5% CO2 for diverse times, the cells were washed with PBS and harvested, and total RNAs and soluble proteins from the above-stimulated cells were prepared for qPCR and Western blotting analysis, respectively [5, 12].
Immunofluorescence test (IFT)
IFT was performed to investigate the binding of rTsDPP1 and RAW264.7 macrophages as previously described [5, 36]. Briefly, macrophages were cultured on a cover glass in a 6-well plate and cultured until the cells reached over 80% confluence. After washing with PBS three times, the cells were fixed with 4% paraformaldehyde for 20 min at room temperature, incubated with 20 µg/mL proteins (rTsDPP1, AW ESA and TRX tag protein) at 37 °C for 2 h, blocked with 5% goat serum at 37 °C for 1 h, and then incubated with 1:10 dilutions of different serum (anti-rTsDPP1 serum, infection serum and preimmune serum) at 37 °C for 1 h. Alexa Fluor 488-conjugated anti-mouse IgG (1:100; Abways, Shanghai, China) served as the secondary antibody, and 4′,6-diamidino-2-phenylindole (DAPI) was used to dye the cell nucleus. The fluorescence signal was observed under fluorescence and confocal microscopy (Olympus, Tokyo, Japan) [37].
Western blotting analysis
Soluble cellular proteins were prepared from induced RAW264.7 and peritoneal macrophages using ice-cold cell lysis buffer (Beyotime, Shanghai, China) containing 1 mM phenylmethylsulfonyl fluoride (PMSF). The cell protein concentration was measured using a BCA assay kit (Solarbio, Beijing, China) [38, 39]. Cell proteins were separated by 10% SDS–PAGE, transferred onto polyvinylidene difluoride (PVDF) membranes (Millipore, USA), blocked with 5% skim milk in Tris-buffered saline (TBS) containing 0.05% Tween 20 (TBST) for 2 h, and then incubated with the following primary antibodies in TBST overnight at 4 °C: anti-iNOS antibody (1:10 000; Abcam, London, UK), anti-STAT6 antibody (1:1000; Proteintech, Rosement, USA), anti-phosphorylated (p)-STAT6 (Tyr641) antibody (1:1000; Abmart, Shanghai, China), anti-PPARγ antibody (1:1000; Proteintech, USA), anti-Arg1 antibody (1:1000; Proteintech) and anti-tubulin antibody (1:5000; Abcam). After washing with PBST, the membranes were incubated with HRP-conjugated IgG (1:5000; Southern Biotech., USA) at room temperature for 1 h and visualized by Omni-ECLTm reagents (Epizyme, Shanghai, China) using a chemiluminescent gel imaging system (Tanon 5200, Shanghai, China). The relative intensities of each protein band were analysed using ImageJ software (National Institutes of Health, Bethesda, Maryland, USA) [24, 40, 41].
Real-time quantitative PCR (qPCR)
Total RNA was extracted from RAW264.7 cells and peritoneal macrophages by TRIzol reagent (Invitrogen, USA) and quantified by determining the absorbance at 260 nm. A cDNA synthesis kit (Takara, Tokyo, Japan) was used to reverse-transcribe mRNA to cDNA, and all qPCRs were performed in triplicate using the SYBR Green PCR master mix (Takara, Tokyo, Japan) in the ABI Prism 7500 Fast Sequence Detection System (Applied Biosystems, USA) [42, 43]. The sequences of primers used for PCR amplification are shown in Table 1 [44, 45]. Fold expression of target gene expression was calculated with the 2−ΔΔCt method by normalization to the internal control GAPDH gene [46].
Flow cytometry
RAW264.7 and peritoneal macrophages were pretreated as described above, and the cells were washed with PBS three times and resuspended in FACS buffer (PBS, 0.1% BSA and 0.5 mM EDTA) for staining. Cells were blocked with anti-mouse CD16/CD32 antibody (mouse Fc blocker, 1:100; BD Biosciences, USA) for 20 min on ice for flow cytometry. The cells were incubated with fluorescently labelled antibodies on ice in the dark for 20 min and then washed with FACS buffer. Macrophages were identified with V450-anti-F4/80 (eBioscience, USA) and PerCP-Cyanine5.5-anti-CD11b (eBioscience). PE-anti-CD86 (eBioscience) was used as an M1 marker, APC-anti-CD206 (Biolegend, USA) served as an M2 marker, and PE-anti-CD64 (Biolegend) was used to recognize FcγR. For analysis of intracellular molecules, the cells were permeabilized by a Fix & Perm Kit (Multisciences (Lianke) Biotech Hangzhou, China) and stained with APC-anti-CD206 intracellularly. Finally, the cells were analysed using a BD FACS Canto flow cytometer (BD Biosciences). Data were further analysed using FlowJo software (Ashland, OR, USA) [47, 48].
Assay of nitric oxide (NO)
Based on the Griess reaction, the enriched nitrite in the medium was used as an indicator of nitric oxide (NO) production [49]. Briefly, RAW264.7 macrophages were divided into three groups: one group of macrophages was cultured with 20 µg/mL rTsDPP1, AW ESA, TRX and IL-4, and 200 ng/mL LPS alone at 37 °C for 24 h; another group was first incubated with LPS for 24 h, then cultured with rTsDPP1, AW ESA and IL-4 for 24 h; the third group was preincubated with LPS for 24 h, then cultured with the STAT6 inhibitor (AS1517499, 100 nM) or the PPARγ antagonist (GW9662, 10 µM) for 24 h [50, 51], and finally incubated with rTsDPP1, TRX, AW ESA and IL-4 for 24 h. Culture supernatant was collected and successively mixed with Griess Reagent I and II (Beyotime, Shanghai, China). After incubation at room temperature for 5 min, the absorbance of the solution at 540 nm was measured using a microplate reader. The standard curve was drawn according to the different concentrations of NaNO2.
Antibody-dependent cell-mediated cytotoxicity assay
Peritoneal macrophages from normal BALB/c mice were collected as previously described [52]. The macrophages were incubated with various proteins (rTsDPP1, AW ESA, TRX, LPS and IL-4) for 24 h. The cells were washed with PBS and adjusted to 2 × 105 cells in a 96-well plate with RPMI-1640 medium. Fifty newborn larvae (NBL) were added to the medium containing T. spiralis-infected murine serum (1:100 dilutions) and incubated at 37 °C for 72 h. In addition, the serum used in the ADCC assay was pretreated at 56 °C for 30 min to inactivate the complement component, and normal heath mouse serum was used as a negative control. To further identify the mechanisms by which rTsDPP1 inhibits CD64 expression and reduces the cytotoxicity of rTsDPP1-incubated macrophages, macrophages pretreated with a STAT6 inhibitor (AS1517499, 100 nM) or a PPARγ antagonist (GW9662, 10 µM) for 24 h were also incubated with various proteins. After the NBL were cultured with various groups of macrophages and infection serum, larval viability was assessed based on larval morphology and activity. The living NBL were active and mobile, whereas the dead NBL were inactive and straight. Cytotoxicity was defined as the percentage of dead NBL to the number of total larvae observed in each assay [53, 54].
Statistical analysis
Statistical analysis was performed using GraphPad Prism V.9.5 (GraphPad Software Inc., USA), and data are shown as the mean ± standard error of the mean (SEM). Comparisons between two groups at multiple time points were conducted by two-way analysis of variance (ANOVA) with Sidak’s multiple comparisons test. An unpaired Student’s t test was used to determine the significant differences between two groups. Comparisons of more than two groups were performed using one-way ANOVA for multiple comparisons. P < 0.05 was defined as statistically significant.
Results
The effect of rTsDPP1 on the cell viability of RAW264.7 macrophages
After RAW264.7 macrophages were incubated with different concentrations of rTsDPP1 (5, 10, 15, 20 and 25 µg/mL) for 24 and 48 h, cell viability was evaluated by a CCK-8 assay. The results showed that 5–25 µg/mL TsDPP1 had no obvious effects on cell viability at 24 h (F = 0.05369, P > 0.05), but 25 µg/mL rTsDPP1 or AW ESA obviously decreased cell viability at 48 h compared to the PBS group (trTsDPP1 = 6.028, P < 0.05; tAW ESA = 10.551, P < 0.01) (Figure 1). Therefore, 20 µg/mL rTsDPP1 was used in the following experiments.
rTsDPP1 binding to RAW264.7 macrophage membranes
To investigate the binding between rTsDPP1 and macrophages, IFT and confocal microscopy were performed. The results showed that after incubation with rTsDPP1, bright green fluorescence on the surface of macrophages was detected by anti-rTsDPP1 serum and infection serum (Figure 2A). Confocal microscopy revealed that the binding site of rTsDPP1 and macrophages was localized on the cell membrane (Figure 2B). The results indicated that rTsDPP1 had the ability to bind to macrophages.
rTsDPP1 promotes macrophage M2 polarization via the STAT6/PPARγ pathway
To evaluate the roles of rTsDPP1 in macrophage polarization, the murine monocyte/macrophage line RAW264.7 and murine peritoneal macrophages were used for the in vitro stimulation of M1 and M2 phenotypes. Western blotting showed that after RAW264.7 macrophages were stimulated with 20 µg/mL rTsDPP1 or AW ESA at 37 °C for 2 h, the expression level of iNOS (M1) was not evidently changed compared to that in the PBS group (F = 9.895, PrTsDPP1 > 0.05, PESA > 0.05), but the protein expression level of Arg1 (M2) was obviously increased (F = 30.44, PrTsDPP1 < 0.05, PESA < 0.001) (Figures 3A–C). To further study the mechanism by which rTsDPP1 induces macrophage polarization, murine peritoneal macrophages were also stimulated. The results showed that the expression level of iNOS (M1) was not statistically changed compared to that in the PBS group (F = 5.479, PrTsDPP1 > 0.05, PESA > 0.05), but the Arg1 expression level in the rTsDPP1 and AW ESA groups was significantly higher than that in the PBS group (F = 31.22, PrTsDPP1 < 0.05, PAW ESA < 0.001) (Figures 4A–C), which was consistent with the findings in RAW264.7 macrophages. Moreover, the protein expression of p-STAT6, STAT6 and PPARγ in the rTsDPP1-treated group was evidently increased compared to that in the PBS group (P < 0.05) (Figures 4D–F). The results suggested that rTsDPP1 elicited macrophage M2 polarization in vitro, as demonstrated by the expression level of Arg1 (M2 marker) being clearly increased via the activation of the STAT6/PPARγ pathway.
Upregulation of M2-related genes in rTsDPP1-treated macrophages
To investigate the role of rTsDPP1 in macrophage polarization, RAW264.7 and peritoneal macrophages were treated with various proteins, and the mRNA expression levels of M1/M2-related genes were analysed by qPCR. The results revealed that in rTsDPP1-treated RAW264.7 macrophages, the mRNA expression of M1 genes (IL-1β, TNF-α, IL-6 and iNOS) was not obviously changed compared to that in the PBS group (FIL−1β = 3525, FTNF−α = 4099, FIL−6 = 165.8, FiNOS = 1725, P > 0.05), but rTsDPP1 evidently upregulated the mRNA expression of M2 genes (IL-10, TGF-β, CD206 and Arg1) compared to that in the PBS group (FIL−10 = 109.4, FTGF−β = 453.0, FCD206 = 605.9, FArg1 = 482.7, P < 0.0001) (Figure 5). Furthermore, after murine peritoneal macrophages were treated with rTsDPP1, compared to the PBS group, the mRNA expression of M1 genes was not obviously changed (FIL−1β = 569.4, FTNF−α = 27.14, FIL−6 = 74.22, FiNOS = 48.22, P > 0.05), but the mRNA expression of M2 genes was significantly increased (FIL−10 = 75.52, FTGF−β = 359.7, FCD206 = 134.8, FArg1 = 2489, P < 0.0001) (Figure 6). The results demonstrated that rTsDPP1 induced the activation of M2 phenotypic macrophages (Arg-1 and CD206) and evidently increased the mRNA expression levels of anti-inflammatory cytokines (IL-10 and TGF-β) in M2-polarized macrophages.
rTsDPP1 induced high expression of the M2 marker CD206 in macrophages
Flow cytometry was conducted to further investigate rTsDPP1-induced macrophage polarization. RAW264.7 macrophages were gated by F4/80, and CD86 and CD206 were used as M1 and M2 markers, respectively. The results showed that compared to that in the PBS group, the M1 marker (CD86) expression level was not changed in cells treated with rTsDPP1 (F = 37.17, P = 0.9998) (Figure 7A), but the M2 marker (CD206) expression level was obviously increased (F = 63.89, P < 0.01) (Figure 7B). Similarly, after murine peritoneal macrophages were stimulated with rTsDPP1 and AW ESA, compared to the PBS group, no significant change in M1 marker (F4/80 + CD11b + CD86 + cells) expression level was observed (F = 67.16, P ˃ 0.05) (Figure 8A); however, the macrophages showed a high expression of F4/80 + CD11b + CD206 + cells (F = 168.6, P < 0.01) (Figure 8B), demonstrating that rTsDPP1 promoted macrophage polarization towards the M2 type.
STAT6 inhibitor and PPARγ antagonist abrogated rTsDPP1-induced M2 polarization
As described above in the subsection “rTsDPP1 promotes macrophage M2 polarization via the STAT6/PPARγ pathway”, rTsDPP1 induced macrophage M2 polarization through the activation of the STAT6/PPARγ pathway. To further confirm the critical roles of STAT6 and PPARγ signals in rTsDPP1 triggering peritoneal macrophage polarization, the STAT6 inhibitor (AS1517499, 100 nM) and the PPARγ antagonist (GW9662, 10 µM) were preincubated with mouse peritoneal macrophages at 37 °C for 2 h. The qPCR results showed that the transcript levels of M2 genes (IL-10, TGF-β, CD206 and Arg1) were obviously downregulated by the STAT6 inhibitor compared to the rTsDPP1 only group (tIL−10 = 5.403, tTGF−β = 7.213, tCD206 = 48.940, tArg1 = 11.253, P < 0.01) (Figure 9). Western blotting results revealed that the rTsDPP1-upregulated expression levels of p-STAT6, STAT6, PPARγ and Arg1 were also significantly reduced and restored to the PBS group level by the STAT6 inhibitor (tp−STAT6 = 3.326, tSTAT6 = 3.538, tPPARγ = 4.753, tArg1 = 5.395, P < 0.05) (Figure 10). The results suggested that the STAT6 inhibitor completely inhibited and blocked the STAT6/PPARγ pathway and the activation of macrophage M2 polarization.
Furthermore, compared to the PBS group, the mRNA expression levels of M2 cytokines and markers (IL-10, TGF-β, CD206 and Arg1) were notably decreased after macrophages were treated with a PPARγ antagonist (GW9662) (tIL−10 = 6.334, tTGF−β = 6.457, tCD206 = 14.836, tArg1 = 25.872, P < 0.01) (Figure 11). Although the PPARγ antagonist (GW9662) had no obvious impact on the rTsDPP1-induced high expression of p-STAT6 and STAT6 (tp−STAT6 = 0.07794, tArg1 = 0.7620, P ˃ 0.05), after peritoneal macrophages were treated with the PPARγ antagonist, the expression levels of PPARγ and Arg1 (M2 marker) were obviously reduced (tPPARγ = 3.581, tArg1 = 8.026, P < 0.05) (Figure 12). The results indicated that rTsDPP1 directly facilitated M2 macrophage polarization by activating the STAT6-PPARγ signalling pathway, and the facilitation role was completely abrogated by a STAT6 inhibitor and PPARγ antagonist.
The inhibition of macrophage NO production by rTsDPP1
To assess the effect of rTsDPP1 on NO production in RAW264.7 macrophages, a Griess reaction was performed. The standard curve of NO concentration was constructed according to the OD values at 540 nm of a series of concentrations of NaNO2 (Figure 13A). The results showed that NO production in LPS-treated macrophages was obviously increased compared to that in the PBS group (F = 259.2, P < 0.0001), but NO production in macrophages treated only with rTsDPP1, AW ESA, TRX or IL-4 was not evidently changed relative to that in the PBS group (F = 259.2, P > 0.05). Moreover, after incubation with rTsDPP1, AW ESA and IL-4, NO production in LPS-treated macrophages was also significantly decreased compared to that in the LPS-only group (F = 259.2, P < 0.0001) (Figure 13B). However, both the STAT6 inhibitor and PPARγ antagonist also abrogated the function of rTsDPP1 in reducing LPS-induced NO production (F = 537.8, P > 0.05); namely, the inhibitor and antagonist also increased and restored NO production in LPS + rTsDPP1-treated macrophages (Figure 13C). These results suggest that rTsDPP1 suppressed LPS-induced NO production in macrophages through the STAT6/PPARγ pathway.
rTsDPP1 suppressed the mRNA expression of FcγR I (CD64) and cytotoxicity of macrophages via the STAT6/PPARγ pathway
To identify the effect of rTsDPP1 on the expression of FcγR I (CD64) on macrophages, macrophages cultured with rTsDPP1 were analysed by flow cytometry. The results showed that the mean fluorescence intensity of CD64+ macrophages was decreased by 15.72% compared to that in the PBS group (F = 265.1, P < 0.0001) (Figures 14A and B), indicating that rTsDPP1 significantly suppressed CD64 expression on the surface of macrophages. Furthermore, qPCR results demonstrated that after macrophages were incubated with rTsDPP1, CD64 mRNA expression on macrophages was reduced by 32.90% compared to that in the PBS group (F = 161.0, P < 0.01) (Figure 14C). The results suggested that the binding capacity of FcγR I on macrophages with anti-Trichinella IgG antibodies was evidently decreased due to the reduction in CD64 expression levels on macrophages treated with rTsDPP1. Subsequently, the ability of macrophages to kill NBL through ADCC was obviously reduced, and the cytotoxicity (larval death rate) of rTsDPP1-treated macrophages was decreased by 22.37% compared to that of the PBS group (F = 86.37, P < 0.01) (Figure 14D). This result was consistent with that of rTsDPP1 activating macrophage M2 polarization, which decreased the expression of killing molecules (NO) and anti-inflammatory cytokines (IL-10 and TGF-β). The results suggested that rTsDPP1-activated macrophage M2 polarization and decreased FcγR I expression might be beneficial to the survival of T. spiralis nematodes and mediate their immune evasion in hosts.
To further identify the mechanisms by which rTsDPP1 inhibits CD64 expression and reduces the cytotoxicity of rTsDPP1-incubated macrophages, a STAT6 inhibitor (AS1517499) and PPARγ antagonist (GW9662) were also used to treat macrophages. The qPCR results showed that both AS1517499 and GW9662 evidently abrogated the suppressive effect of rTsDPP1 on CD64 expression relative to rTsDPP1 alone (F = 67.58, P < 0.0001) (Figure 15A). The rTsDPP1-suppressed cytotoxicity of ADCC killing NBL was also obviously regained by using AS1517499 and GW9662 compared to the rTsDPP1 alone group (F = 36.41, P < 0.0001) (Figure 15B). The NBL in the rTsDPP1 group had stronger motile ability, and fewer macrophages adhered to the NBL. However, in the AS1517499- and GW9662-treated macrophages, cytotoxicity was also enhanced, as demonstrated by the weakened NBL activity and increased number of macrophages attached to the NBL (Figure 16). The results suggested that the inhibitory effect of rTsDPP1 on macrophage FcγR I expression was involved in the activation of the STAT6/PPARγ pathway. Therefore, our results demonstrated that rTsDPP1 suppressed the mRNA expression of CD64 and inhibited macrophage-mediated ADCC, which was dependent on the activation of the STAT6/PPARγ pathway.
Discussion
During T. spiralis infection, the host produces a strong immune response, which results in substantial damage to the host’s tissues and cells. To alleviate the damage in the host and to maintain long-term survival, which are necessary to create a balanced immune environment that benefits its parasitism, T. spiralis releases multiple immunoregulatory factors. Some studies have shown that T. spiralis ESA reduced the secretion of IL-1, IL-6, and IL-12 in LPS-stimulated macrophages and reduced the phosphorylation of ERK1/2 and p38 MAPK in macrophages. Additionally, ESA alone upregulated the expression of IL-10, TGF-β and Arg1 in macrophages [23, 55]. Recent studies revealed that AW ESA significantly upregulated the expression of CD206 and Arg-1 in macrophages and attenuated DSS-induced murine colitis by activating M2 macrophage polarization [24]. TsDPP1 was a highly expressed ESA of intestinal T. spiralis stages (IIL and AW), but its immune regulatory role in macrophages is largely unknown.
In the current study, to investigate the effect of rTsDPP1 on the polarization of RAW264.7 and mouse peritoneal macrophages, endotoxin-free rTsDPP1 was used to directly stimulate macrophages, and LPS served as the inducer of M1 and IL-4 as the inducer of M2. The AW ESA and TRX tag proteins of rTsDPP1 were used as positive and negative controls, respectively. The results of the CCK-8 assay showed that the appropriate concentration of rTsDPP1 to stimulate macrophages was 20 µg/mL; this dose had no obvious effects on cell viability. The results of IFT and confocal microscopy revealed that rTsDPP1 specifically bound to macrophages, and the binding site was localized on the cell membrane of macrophages, suggesting that there is an interaction between rTsDPP1 and host macrophages [39]. However, the TsDPP1-specific receptor on the surface of macrophages is still unclear, and it is necessary to further characterize the properties of TsDPP1-binding receptors on macrophages by coimmunoprecipitation, pull-down assays and mass spectrometry in future experiments.
To investigate the effect of rTsDPP1 on macrophage polarization, the expression of M1/M2 macrophages effector molecules was also measured in this study. The results revealed that rTsDPP1 induced high expression of Arg1 (M2-specific) in RAW264.7 macrophages but had no obvious effects on the expression level of iNOS (M1-specific), indicating that rTsDPP1 promoted M2 polarization in RAW264.7 macrophages. Moreover, the transcript levels of M2 genes (TGF-β, IL-10, CD206 and Arg1) and the surface molecule CD206 were found to be significantly increased in rTsDPP1-treated macrophages. The consistent immunomodulatory effects of rTsDPP1 on macrophage polarization were further confirmed in murine peritoneal macrophages. In contrast, the TRX tag protein had no evident effect on macrophage polarization. The results indicated that rTsDPP1 had the capacity to directly polarize macrophages to an M2 phenotype in vitro, and that peritoneal macrophages possessed the same ability to be polarized to the M2 phenotype and produce cytokines as RAW264.7 cells [56]. These findings are in accordance with the macrophage M2 polarization in T. spiralis infection and in after stimulation with AW ES products [24, 57]. Anti-inflammatory cytokines (TGF-β and IL-10) secreted by M2 macrophages were crucial to suppress excessive inflammatory reactions during Trichinella infection.
IL-4 and IL-13 are produced during helminth infections, which in turn activates the IL-4R/STAT signalling pathway [58]. After binding with IL-4Rα, a receptor on the surface of macrophages, IL-4 activates the intracellular tyrosine kinase JAK1 and further activates the downstream protein STAT6. Phosphorylated STAT6 binds to PPARγ and enters the cell nucleus to upregulate the expression of M2-type macrophage-related genes [59]. However, T. spiralis infection induces M2-type macrophage polarization in IL-4R-deficient mice, and this process is still dependent on STAT, suggesting that STAT is a key signalling molecule in M2 macrophage polarization [33]. In the present study, our results revealed that the expression levels of p-STAT6, STAT6 and PPARγ were significantly increased in rTsDPP1-treated peritoneal macrophages, suggesting that the mechanism by which rTsDPP1 activates M2-type macrophages is also dependent on the STAT6/PPARγ pathway. To further verify this hypothesis, a STAT6 inhibitor (AS1517499) and PPARγ antagonist (GW9662) were used to inhibit the effect of rTsDPP1-induced macrophage polarization in this study. The results showed that the two inhibitors abrogated the role of rTsDPP1 in inducing M2 polarization, as demonstrated by the fact that rTsDPP1 induced high expression of p-STAT6, STAT6 and PPARγ and that the high transcript levels of the TGF-β, IL-10, CD206 and Arg1 genes were evidently abrogated by the two inhibitors. The results indicated that the effect of rTsDPP1 on inducing macrophage M2 polarization was dependent on the activation of the STAT6/PPARγ pathway [50].
Macrophages, as a main effector cell, can directly kill and destroy T. spiralis NBL by producing and releasing NO and mediating the function of ADCC [21]. In this study, the release of NO in rTsDPP1-treated macrophages preinduced by LPS was also assayed. The results showed that rTsDPP1 reduced the NO synthesis and secretion by macrophages stimulated by LPS due to its activation of macrophage M2 polarization. FcR I (CD64), a receptor that binds to the antibody IgG Fc fragment on the surface of macrophages, is a key surface molecule that enables macrophages to mediate ADCC [60]. The flow cytometry results found that the mean fluorescence intensity of CD64 protein in macrophages stimulated by rTsDPP1 was distinctly reduced, and the qPCR results also showed that the transcript level of the CD64 gene was overtly decreased. Consequently, the larval killing capacity of rTsDPP1-treated macrophages via ADCC was also significantly reduced. Moreover, the rTsDPP1 inhibitory role on CD64 expression and the cytotoxicity of macrophages was clearly abrogated by using a STAT6 inhibitor and PPARγ antagonist, further suggesting that the rTsDPP1 inhibitory role was also involved in the activation of the STAT6/PPARγ pathway.
In conclusion, our results showed that rTsDPP1 had the ability to upregulate the expression of Arg1 and CD206 and increase the transcript levels of the TGF-β, IL-10, CD206 and Arg1 genes, which drove macrophages to the M2 phenotype by activating the STAT6/PPARγ pathway. The synthesis and release of NO were obviously reduced in rTsDPP1-activated M2 macrophages. Moreover, the cytotoxicity and larval killing capacity of rTsDPP1-induced M2 polarized macrophages via ADCC was also significantly reduced due to the downregulated expression of FcR I (CD64) and NO. The function of rTsDPP1 in promoting macrophage M2 polarization might contribute to the production of the immunosuppressive factors TGF-β and IL-10, which could regulate the host’s inflammatory responses to T. spiralis infection. This anti-inflammatory process might be beneficial to the parasitism and immune evasion of the nematode. The results of this study provide novel insights to further understand the mechanisms of immunomodulation and immune evasion by Trichinella during infection.
Abbreviations
- ML:
-
muscle larvae
- IIL:
-
intestine infective larvae
- AW:
-
adult worms
- NBL:
-
newborn larvae
- ESA:
-
excretory-secretory antigens
- M1:
-
classical activated macrophage
- M2:
-
alternative activated macrophage
- LPS:
-
lipopolysaccharide
- rTsDPP1:
-
recombinant T. spiralis dipeptidyl peptidase I
- ADCC:
-
antibody-dependent cell-mediated cytotoxicity
- FcR:
-
Fc receptor
- NO:
-
nitric oxide
- dpi:
-
days post-infection
- PEC:
-
peritoneal exudate cells
- TRX:
-
thioredoxin
- IFT:
-
immunofluorescence test
- DAPI:
-
4′,6-Diamidino-2-phenylindole
- PMSF:
-
phenylmethylsulfonyl fluoride
- PVDF:
-
polyvinylidene difluoride
- TBST:
-
Tris-buffered saline Tween
- HRP:
-
horseradish peroxidase
- qPCR:
-
real-time quantitative PCR
- FSC-A:
-
forwards scatter-area
- FSC-H:
-
forwards scatter-height
References
Ribicich MM, Farina FA, Aronowicz T, Ercole ME, Bessi C, Winter M, Pasqualetti MI (2020) A review on Trichinella infection in South America. Vet Parasitol 285:109234
Zhang XZ, Wang ZQ, Cui J (2022) Epidemiology of trichinellosis in the People’s Republic of China during 2009–2020. Acta Trop 229:106388
Ren HN, Zhuo TX, Bai SJ, Bai Y, Sun XY, Liu RD, Long SR, Cui J, Wang ZQ (2021) Proteomic analysis of hydrolytic proteases in excretory/secretory proteins from Trichinella spiralis intestinal infective larvae using zymography combined with shotgun LC-MS/MS approach. Acta Trop 216:105825
Yue X, Sun XY, Liu F, Hu CX, Bai Y, Yang QD, Liu RD, Zhang X, Cui J, Wang ZQ (2020) Molecular characterization of a Trichinella spiralis serine proteinase. Vet Res 51:125
Hu YY, Zhang R, Yan SW, Yue WW, Zhang JH, Liu RD, Long SR, Cui J, Wang ZQ (2021) Characterization of a novel cysteine protease in Trichinella spiralis and its role in larval intrusion, development and fecundity. Vet Res 52:113
Lei JJ, Hu YY, Liu F, Yan SW, Liu RD, Long SR, Jiang P, Cui J, Wang ZQ (2020) Molecular cloning and characterization of a novel peptidase from Trichinella spiralis and protective immunity elicited by the peptidase in BALB/c mice. Vet Res 51:111
Xu YXY, Zhang XZ, Weng MM, Cheng YK, Liu RD, Long SR, Wang ZQ, Cui J (2022) Oral immunization of mice with recombinant Lactobacillus plantarum expressing a trichinella spiralis galectin induces an immune protection against larval challenge. Parasit Vectors 15:475
Li LG, Wang ZQ, Liu RD, Yang X, Liu LN, Sun GG, Jiang P, Zhang X, Zhang GY, Cui J (2015) Trichinella spiralis: low vaccine potential of glutathione S-transferase against infections in mice. Acta Trop 146:25–32
Kosanovic M, Cvetkovic J, Gruden-Movsesijan A, Vasilev S, Svetlana M, Ilic N, Sofronic-Milosavljevic L (2019) Trichinella spiralis muscle larvae release extracellular vesicles with immunomodulatory properties. Parasite Immunol 41:e12665
Sofronic-Milosavljevic L, Ilic N, Pinelli E, Gruden-Movsesijan A (2015) Secretory products of Trichinella spiralis muscle larvae and immunomodulation: implication for autoimmune diseases, allergies, and malignancies. J Immunol Res 2015:523875
Bruschi F, Ashour DS, Othman AA (2022) Trichinella-induced immunomodulation: another tale of helminth success. Food Waterborne Parasitol 27:e00164
Han CX, Yu J, Zhang ZQ, Zhai P, Zhang Y, Meng S, Yu Y, Li XY, Song MX (2019) Immunomodulatory effects of Trichinella spiralis excretory-secretory antigens on macrophages. Exp Parasitol 196:68–72
Nagano I, Wu ZL, Takahashi Y (2009) Functional genes and proteins of Trichinella spp. Parasitol Res 104:197–207
Cvetkovic J, Sofronic-Milosavljevic L, Ilic N, Gnjatovic M, Nagano I, Gruden-Movsesijan A (2016) Immunomodulatory potential of particular Trichinella spiralis muscle larvae excretory-secretory components. Int J Parasitol 46:833–842
Liu RD, Jiang P, Wen H, Duan JY, Wang LA, Li JF, Liu CY, Sun GG, Wang ZQ, Cui J (2016) Screening and characterization of early diagnostic antigens in excretory-secretory proteins from Trichinella spiralis intestinal infective larvae by immunoproteomics. Parasitol Res 115:615–622
Nutman TB (2015) Looking beyond the induction of Th2 responses to explain immunomodulation by helminths. Parasite Immunol 37:304–313
Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S, Gordon S, Hamilton JA, Ivashkiv LB, Lawrence T, Locati M, Mantovani A, Martinez FO, Mege JL, Mosser DM, Natoli G, Saeij JP, Schultze JL, Shirey KA, Sica A, Suttles J, Udalova I, van Ginderachter JA, Vogel SN, Wynn TA (2014) Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41:14–20
Rolot M, Dewals BG (2018) Macrophage activation and functions during helminth infection: recent advances from the laboratory mouse. J Immunol Res 2018:2790627
Moskwa B (1999) Trichinella spiralis: in vitro cytotoxicity of peritoneal cells against synchronous newborn larvae of different age. Parasitol Res 85:59–63
Ren HN, Guo KX, Zhang Y, Sun GG, Liu RD, Jiang P, Zhang X, Wang L, Cui J, Wang ZQ (2018) Molecular characterization of a 31 kDa protein from Trichinella spiralis and its induced immune protection in BALB/c mice. Parasit Vectors 11:625
Gansmuller A, Anteunis A, Venturiello SM, Bruschi F, Binaghi RA (1987) Antibody-dependent invitro cytotoxicity of newborn Trichinella spiralis larvae-nature of the cells involved. Parasite Immunol 9:281–292
Zhang XZ, Yue WW, Bai SJ, Hao HN, Song YY, Long SR, Liu RD, Cui J, Wang ZQ (2022) Oral immunization with attenuated Salmonella encoding an elastase elicits protective immunity against Trichinella spiralis infection. Acta Trop 226:106263
Bai X, Wu XP, Wang XL, Guan ZH, Gao F, Yu JL, Yu L, Tang B, Liu XL, Song YX, Wang XR, Radu B, Boireau P, Wang F, Liu MY (2012) Regulation of cytokine expression in murine macrophages stimulated by excretory/secretory products from Trichinella spiralis in vitro. Mol Cell Biochem 360:79–88
Wang ZX, Hao CY, Zhuang QH, Zhan B, Sun XM, Huang JJ, Cheng YL, Zhu XP (2020) Excretory/secretory products from Trichinella spiralis adult worms attenuated DSS-induced colitis in mice by driving PD-1-mediated M2 macrophage polarization. Front Immunol 11:563784
Liu YM, Zou XQ, Ou ML, Ye XH, Zhang BH, Wu TY, Dong SR, Chen XJ, Liu HX, Zheng Z, Zhao JR, Wu J, Liu DD, Wen ZH, Wang Y, Zheng SL, Zhu KH, Huang XX, Du XB, Liang JY, Luo XL, Xie YF, Wu M, Lu CY, Xie X, Liu KL, Ying YT, Qi GL, Jing CX, Yang G (2019) Toxoplasma gondii cathepsin C1 inhibits NF-kappa B signalling through the positive regulation of the HIF-1 alpha/EPO axis. Acta Trop 195:35–43
Bai Y, Ma KN, Sun XY, Liu RD, Long SR, Jiang P, Wang ZQ, Cui J (2021) Molecular characterization of a novel cathepsin L from Trichinella spiralis and its participation in invasion, development and reproduction. Acta Trop 224:106112
Cheng YL, Yu Y, Zhuang QH, Wang L, Zhan B, Du SQ, Liu YQ, Huang JJ, Hao JF, Zhu XP (2022) Bone erosion in inflammatory arthritis is attenuated by Trichinella spiralis through inhibiting M1 monocyte/macrophage polarization. iScience 25:103979
Liu RD, Cui J, Liu XL, Jiang P, Sun GG, Zhang X, Long SR, Wang L, Wang ZQ (2015) Comparative proteomic analysis of surface proteins of Trichinella spiralis muscle larvae and intestinal infective larvae. Acta Trop 150:79–86
Sun GG, Liu RD, Wang ZQ, Jiang P, Wang L, Liu XL, Liu CY, Zhang X, Cui J (2015) New diagnostic antigens for early trichinellosis: the excretory-secretory antigens of Trichinella spiralis intestinal infective larvae. Parasitol Res 114:4637–4644
Song YY, Zhang Y, Ren HN, Sun GG, Qi X, Yang F, Jiang P, Zhang X, Cui J, Wang ZQ (2018) Characterization of a serine protease inhibitor from Trichinella spiralis and its participation in larval invasion of host’s intestinal epithelial cells. Parasit Vectors 11:499
Xu JY, Yu PC, Wu LJ, Liu MX, Lu YX (2019) Regulatory effect of two Trichinella spiralis serine protease inhibitors on the host’s immune system. Sci Rep 9:17045
Zhan JH, Yao JP, Liu W, Hu XC, Wu ZD, Zhou XW (2013) Analysis of a novel cathepsin B circulating antigen and its response to drug treatment in Trichinella-infected mice. Parasitol Res 112:3213–3222
Du LL, Wei HY, Li LQ, Shan H, Yu Y, Wang YS, Zhang GS (2014) Regulation of recombinant trichinella spiralis 53-kDa protein (rTsP53) on alternatively activated macrophages via STAT6 but not IL-4R alpha in vitro. Cell Immunol 288:1–7
Wang RB, Zhang YH, Zhen JB, Zhang JP, Pang ZX, Song XW, Lin LH, Sun F, Lu YX (2022) Effects of exosomes derived from Trichinella spiralis infective larvae on intestinal epithelial barrier function. Vet Res 53:87
Mily A, Kalsum S, Loreti MG, Rekha RS, Muvva JR, Lourda M, Brighenti S (2020) Polarization of M1 and M2 human monocyte-derived cells and analysis with flow cytometry upon mycobacterium tuberculosis infection. J Vis Exp 163:e61807
Xu J, Liu RD, Long SR, Song YY, Jiang P, Zhang X, Cui J, Wang ZQ (2020) Characterization of a chymotrypsin-like enzyme from Trichinella spiralis and its facilitation of larva penetration into the host’s enteral epithelial cells. Res Vet Sci 128:1–8
Hao HN, Song YY, Ma KN, Wang BN, Long SR, Liu RD, Zhang X, Wang ZQ, Cui J (2022) A novel C-type lectin from Trichinella spiralis mediates larval invasion of host intestinal epithelial cells. Vet Res 53:85
Han Y, Yue X, Hu CX, Liu F, Liu RD, He MM, Long SR, Cui J, Wang ZQ (2020) Interaction of a Trichinella spiralis cathepsin B with enterocytes promotes the larval intrusion into the cells. Res Vet Sci 130:110–117
Hu CX, Zeng J, Yang DQ, Yue X, Liu RD, Long SR, Zhang X, Jiang P, Cui J, Wang ZQ (2020) Binding of elastase-1 and enterocytes facilitates Trichinella spiralis larval intrusion of the host’s intestinal epithelium. Acta Trop 211:105592
Qi X, Yue X, Han Y, Jiang P, Yang F, Lei JJ, Liu RD, Zhang X, Wang ZQ, Cui J (2018) Characterization of two Trichinella spiralis adult-specific DNase II and their capacity to induce protective immunity. Front Microbiol 9:2504
Sun GG, Song YY, Jiang P, Ren HN, Yan SW, Han Y, Liu RD, Zhang X, Wang ZQ, Cui J (2018) Characterization of a trichinella spiralis putative serine protease. Study of its potential as sero-diagnostic tool. PLoS Negl Trop Dis 12:19
Ren HN, Bai SJ, Wang Z, Han LL, Yan SW, Jiang P, Zhang X, Wang ZQ, Cui J (2021) A metalloproteinase Tsdpy31 from Trichinella spiralis participates in larval molting and development. Int J Biol Macromol 192:883–894
Hu CX, Jiang P, Yue X, Zeng J, Zhang XZ, Song YY, Liu RD, Zhang X, Wang ZQ, Cui J (2020) Molecular characterization of a Trichinella spiralis elastase-1 and its potential as a diagnostic antigen for trichinellosis. Parasit Vectors 13:97
Li R, Li DZ, Wang HA, Chen KW, Wang S, Xu J, Ji P (2022) Exosomes from adipose-derived stem cells regulate M1/M2 macrophage phenotypic polarization to promote bone healing via miR-451a/MIF. Stem Cell Res Ther 13:149
Bardi GT, Smith MA, Hood JL (2018) Melanoma exosomes promote mixed M1 and M2 macrophage polarization. Cytokine 105:63–72
Yang F, Yang DQ, Song YY, Guo KX, Li YL, Long SR, Jiang P, Cui J, Wang ZQ (2019) In vitro silencing of a serine protease inhibitor suppresses Trichinella spiralis invasion, development, and fecundity. Parasitol Res 118:2247–2255
Jin QW, Zhang NZ, Li WH, Qin HT, Liu YJ, Ohiolei JA, Niu DY, Yan HB, Li L, Jia WZ, Song MX, Fu BQ (2020) Trichinella spiralis thioredoxin peroxidase 2 regulates protective Th2 immune response in mice by directly inducing alternatively activated macrophages. Front Immunol 11:2015
Xu N, Bai X, Liu Y, Yang YM, Tang B, Shi HN, Vallee I, Boireau P, Liu XL, Liu MY (2021) The anti-inflammatory immune response in early Trichinella spiralis intestinal infection depends on serine protease inhibitor-mediated alternative activation of macrophages. J Immunol 206:963–977
Sun X, Lv Z, Peng H, Fung M, Yang L, Yang J, Zheng H, Liang J, Wu Z (2012) Effects of a recombinant schistosomal-derived anti-inflammatory molecular (rSj16) on the lipopolysaccharide (LPS)-induced activated RAW264.7. Parasitol Res 110:2429–2437
Huang CY, Wang J, Liu HB, Huang R, Yan XW, Song MY, Tan G, Zhi FC (2022) Ketone body beta-hydroxybutyrate ameliorates colitis by promoting M2 macrophage polarization through the STAT6-dependent signaling pathway. BMC Med 20:148
Liu HY, Wang MY, Jin ZP, Sun DX, Zhu T, Liu XY, Tan XY, Shi GJ (2021) FNDC5 induces M2 macrophage polarization and promotes hepatocellular carcinoma cell growth by affecting the PPAR gamma/NF-kappa B/NLRP3 pathway. Biochem Biophys Res Commun 582:77–85
Zhang XZ, Sun XY, Bai Y, Song YY, Hu CX, Li XR, Cui J, Wang ZQ (2020) Protective immunity in mice vaccinated with a novel elastase-1 significantly decreases Trichinella spiralis fecundity and infection. Vet Res 51:43
Hu CX, Xu YXY, Hao HN, Liu RD, Jiang P, Long SR, Wang ZQ, Cui J (2021) Oral vaccination with recombinant Lactobacillus plantarum encoding Trichinella spiralis inorganic pyrophosphatase elicited a protective immunity in BALB/c mice. PLoS Negl Trop Dis 15:e0009865
Liu CY, Song YY, Ren HN, Sun GG, Liu RD, Jiang P, Long SR, Zhang X, Wang ZQ, Cui J (2017) Cloning and expression of a trichinella spiralis putative glutathione S-transferase and its elicited protective immunity against challenge infections. Parasit Vectors 10:448
Bai X, Wang XL, Tang B, Shi HN, Boireau P, Rosenthal B, Wu XP, Liu MY, Liu XL (2016) The roles of supernatant of macrophage treated by excretory-secretory products from muscle larvae of Trichinella spiralis on the differentiation of C2C12 myoblasts. Vet Parasitol 231:83–91
Oishi S, Takano R, Tamura S, Tani S, Iwaizumi M, Hamaya Y, Takagaki K, Nagata T, Seto S, Horii T, Osawa S, Furuta T, Miyajima H, Sugimoto K (2016) M2 polarization of murine peritoneal macrophages induces regulatory cytokine production and suppresses T-cell proliferation. Immunology 149:320–328
Yang Y, Liu L, Liu XL, Zhang YY, Shi HN, Jia WZ, Zhu HF, Jia H, Liu MY, Bai X (2020) Extracellular vesicles derived from Trichinella spiralis muscle larvae ameliorate TNBS-induced colitis in mice. Front Immunol 11:1174
Becerra-Diaz M, Valderrama-Carvajal H, Terrazas LI (2011) Signal transducers and activators of transcription (STAT) family members in helminth infections. Int J Biol Sci 7:1371–1381
Bhattacharjee A, Shukla M, Yakubenko VP, Mulya A, Kundu S, Cathcart MK (2013) IL-4 and IL-13 employ discrete signaling pathways for target gene expression in alternatively activated monocytes/macrophages. Free Radic Biol Med 54:1–16
Hullsiek R, Li YF, Snyder KM, Wang SM, Di D, Borgatti A, Lee C, Moore PF, Zhu C, Fattori C, Modiano JF, Wu JM, Walcheck B (2022) Examination of IgG fc receptor CD16A and CD64 expression by canine leukocytes and their ADCC activity in engineered NK cells. Front Immunol 13:841859
Acknowledgements
We thank Ms. YY Song and Ms. LL Han for helping with the animal experiments in this study.
Funding
This study was supported by grants from the National Natural Science Foundation of China (No.82372275, 82172300). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author information
Authors and Affiliations
Contributions
Conceptualization: ZQW, JC. Data analysis: SWY. Funding acquisition: JC. Investigation: SWY, RZ, XG, BNW, SRL, RDL, ZQW, JC. Methodology: ZQW, JC. Project administration: ZQW, JC. Resources: ZQW, JC. Supervision: ZQW, JC. Writing–original draft: SWY, ZQW, JC. Writing—review and editing: SWY, ZQW, JC. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Ethics approval and consent to participate
The experimental animals were raised and cared for on the basis of the National Guidelines for Experimental Animal Welfare of the People’s Republic of China (2006). Ethical approval was acquired from the Institutional Life Science Ethics Committee of Zhengzhou University (No. ZZUIRB GZR 2021-0044).
Competing interests
The authors declare that they have no competing interests.
Additional information
Communicated by Frank Katzer.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Yan, S.W., Zhang, R., Guo, X. et al. Trichinella spiralis dipeptidyl peptidase 1 suppressed macrophage cytotoxicity by promoting M2 polarization via the STAT6/PPARγ pathway. Vet Res 54, 77 (2023). https://doi.org/10.1186/s13567-023-01209-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s13567-023-01209-2